Spring Creek Capital’s Zimmer Biomet ZBH Stock Holding History

Spring Creek Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-7,095	Closed	-$768K	–	698
2018 Q2	$768K	Buy	+7,095	New	+$772K	0.09%	217

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Spring Creek Capital's ZBH Position: Q3 2018 in Review

Spring Creek Capital sold out of Zimmer Biomet (ZBH) in Q3 2018, closing a stake of 7,095 shares — an estimated $768K sold.

Spring Creek Capital first reported a position in ZBH in Q2 2018 and held it in 1 quarter. The position peaked at $768K in Q2 2018. 891 funds tracked by Wall St. Rank hold ZBH as of Q3 2018.

Spring Creek Capital reported no remaining Zimmer Biomet position as of Q3 2018 after selling out during the quarter.
Spring Creek Capital sold 7,095 Zimmer Biomet shares in Q3 2018, an estimated $768K.
Spring Creek Capital first reported a position in Zimmer Biomet in Q2 2018 and held it in 1 quarter.
Spring Creek Capital's Zimmer Biomet position peaked at $768K in Q2 2018.
891 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2018.

Based on Spring Creek Capital's 13F filing for Q3 2018, filed 13 Nov 2018.